Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Open in API
Filings indexed 602 across all filing types
Latest filing 2026-05-08 Capital/Financing Update
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
DISCLOSEABLE TRANSACTION - AMENDMENTS TO PARTNERSHIP AGREEMENT
Capital/Financing Update Classification · 95% confidence The document is an announcement by Kindstar Globalgene Technology, Inc. regarding amendments to a partnership agreement, specifically about the duration and management fee of the partnership. It references a previous announcement and provides details on the changes agreed upon by the partners. The document is relatively short (2695 characters) and is structured as a formal announcement to shareholders and the public. There is no financial data, no detailed report, no audit information, no earnings data, and no regulatory certification. The content focuses on a corporate transaction related to partnership terms, which fits the category of a Capital/Financing Update (CAP) as it relates to changes in partnership agreements and investment periods, which are financing-related activities. It is not a report publication announcement or regulatory filing since it contains substantive information about the amendment itself, not just a notice of report availability.
2026-05-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings Classification · 95% confidence The document is a monthly return filed with the Hong Kong Exchanges and Clearing Limited (HKEX) regarding movements in securities for Kindstar Globalgene Technology, Inc. It details authorized and issued share capital, share options, treasury shares, public float sufficiency, and confirmations related to compliance with listing rules. The document is a regulatory submission about share capital and share movements, not a financial report, earnings release, or management discussion. It is not an announcement of a report but a formal regulatory filing with detailed share capital data. Therefore, it fits best under Regulatory Filings (RNS).
2026-05-07 English
DISCLOSEABLE TRANSACTION - AMENDMENTS TO PARTNERSHIP AGREEMENT
Capital/Financing Update Classification · 95% confidence The document is an announcement from Kindstar Globalgene Technology, Inc. regarding amendments to a partnership agreement, specifically about the duration and management fee of the partnership. It is labeled as a "Disclosable Transaction" and provides details about the changes agreed upon by the partners. The document does not contain financial statements, audit information, or detailed financial results. It is not a report but an announcement of a corporate transaction or update related to partnership terms. This fits best under Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. The document length is 2695 characters, which is relatively short but contains substantive information about the partnership amendment, not just a notice or report publication announcement. Therefore, the classification is CAP with high confidence.
2026-05-07 English
PROXY FORM FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, JUNE 5, 2026 (OR ANY ADJOURNMENT THEREOF)
Proxy Solicitation & Information Statement Classification · 98% confidence The document is a proxy form used by shareholders to appoint proxies and vote at the upcoming Annual General Meeting. It does not contain financial results or management discussion but is part of the materials sent to solicit shareholder votes at the AGM. This matches the definition of Proxy Solicitation & Information Statement (PSI).
2026-04-24 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal Notice of Annual General Meeting including the agenda, resolutions to be voted on, proxy appointment instructions, record dates, and voting procedures. It is a solicitation of shareholder votes and information statement for the AGM rather than the AGM presentation itself or the results. This matches the definition of Proxy Solicitation & Information Statement (PSI).
2026-04-24 English
PROPOSED RE-ELECTION OF DIRECTORS PROPOSED RE-APPOINTMENT OF AUDITOR PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND SELL TREASURY SHARES PROPOSED PAYMENT OF FINAL D
AGM Information Classification · 100% confidence The document is a circular related to the Annual General Meeting (AGM) of Kindstar Globalgene Technology, Inc. It includes detailed information about the proposed re-election of directors, re-appointment of auditor, granting of general mandates to repurchase and issue shares, payment of final dividend, and adoption of amended memorandum and articles of association. It also contains the notice of the AGM, proxy arrangements, and other related information. The document is lengthy (15,000 characters) and contains substantive content intended for shareholders to consider before the AGM. This matches the description of AGM Information (AGM-R), which includes presentations and materials shared during the AGM. It is not a full annual report or financial report, nor is it a simple announcement or proxy solicitation. Therefore, the appropriate classification is AGM Information (AGM-R).
2026-04-24 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.